PRESS RELEASE published on 10/11/2023 at 14:30, 2 years 8 months ago Atomic Minerals Announces Consolidation and Financing
PRESS RELEASE published on 08/18/2023 at 22:30, 2 years 10 months ago Atomic Minerals Pauses Drilling at Harts Point Uranium Project, Utah
PRESS RELEASE published on 07/18/2023 at 13:30, 2 years 11 months ago Atomic Minerals Initiates Phase 1 Drilling at Harts Point Uranium Project, Utah
PRESS RELEASE published on 07/14/2023 at 13:30, 2 years 11 months ago Atomic Minerals Proceeds with Debt Settlement Transaction
PRESS RELEASE published on 07/05/2023 at 13:30, 2 years 11 months ago Atomic Minerals Receives Drilling Permit for 20 Drill Pad Locations for Phase I Drill Program at Harts Point Uranium Property, Utah
PRESS RELEASE published on 05/23/2023 at 14:00, 3 years 1 month ago Atomic Minerals Options Colorado Plateau Hosted Harts Point Uranium Property to Kraken Energy
PRESS RELEASE published on 05/02/2023 at 14:00, 3 years 1 month ago Atomic Minerals Options Colorado Plateau Hosted Harts Point Uranium Property to Kraken Energy
PRESS RELEASE published on 02/01/2023 at 14:30, 3 years 4 months ago Atomic Minerals Corp. Options Hamilton Lake and Mitchell Lake in Athabasca Basin and Changes Auditor
Published on 06/30/2026 at 15:00, 1 hour 22 minutes ago Four Nines Gold Advances Toward Maiden Drill Program with Property-Wide Geophysical Survey at Hayden Hill
Published on 06/30/2026 at 15:00, 1 hour 22 minutes ago BlackBerry AtHoc Strengthens Enterprise Readiness as Cyber, Climate, and Geopolitical Uncertainty Rises
Published on 06/30/2026 at 15:00, 1 hour 22 minutes ago Presentation at ESPGHAN 2026 Describes Additional Groundbreaking Results of Evaluation of Jaguar Health's Crofelemer as Adjunctive Oral Therapy for the Treatment of Pediatric Intestinal Failure (IF)
Published on 06/30/2026 at 14:30, 1 hour 52 minutes ago NV Gold Announces Non-Brokered Private Placement
Published on 06/30/2026 at 14:00, 2 hours 22 minutes ago Datametrex Announces Completion of AI-Based Evaluation of 2 Patents and Launch of Licensing Initiative
Published on 06/30/2026 at 16:05, 17 minutes ago Selective PPARα Modulator "K-808" (Pemafibrate) Granted "Breakthrough Therapy" Designation by the U.S. Food and Drug Administration (FDA) As a Treatment for Primary Biliary Cholangitis
Published on 06/30/2026 at 15:06, 1 hour 16 minutes ago 260630 BENETEAU Transactions sur actions propres
Published on 06/30/2026 at 07:30, 8 hours 52 minutes ago Gimv sells its stake in AlpenBlu Clinics (formerly Les Psy Réunis), a Swiss provider of outpatient mental healthcare, to Impact Healthcare.
Published on 06/30/2026 at 07:30, 8 hours 52 minutes ago Gimv cède sa participation dans AlpenBlu Clinics (précédemment Les Psy Réunis), acteur suisse des soins ambulatoires en santé mentale, à Impact Healthcare
